ACLARA BioSciences 1st Quarter 2001 Conference Call

Apr 23, 2001, 01:00 ET from ACLARA BioSciences, Inc.

    MOUNTAIN VIEW, Calif., April 23 /PRNewswire Interactive News Release/ --
 ACLARA BioSciences, Inc. (Nasdaq: ACLA) will conduct a public conference call
 at 10:00 a.m. EDT (7:00 a.m. PDT) on Thursday, April 26, 2001 to discuss
 first quarter 2001 financial results.
     A news release discussing ACLARA's first quarter 2001 financial results
 will be issued Thursday, April 26, 2001, at 9:00 a.m. EDT.
     Leading the conference call will be Joseph Limber, President and CEO of
 ACLARA BioSciences, Inc.
     A live webcast may be accessed by clicking on the following link several
 minutes before the event:
 
     http://www.vcall.com/NASApp/VCall/EventPage?ID=73563
 
     If you are unable to participate in the scheduled call, a replay will be
 made available at 800-642-1687 and accessed by the pass code:  793574.
     ACLARA BioSciences is a leading developer of microfluidic lab-on-a-chip
 technology, having access to the wide range of technology and intellectual
 property required to broadly address the genomics and pharmaceutical drug
 screening markets. The company is developing advanced tools for drug discovery
 and genomics using its proprietary microfluidics array technology and assay
 chemistries. By performing integrated sample processing and analysis on
 plastic microfluidic array LabCard(TM) chips, these tools enable the rapid,
 parallel processing of large numbers of samples while requiring only minute
 volumes of expensive or rare reagents.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X51752588
 
 

SOURCE ACLARA BioSciences, Inc.
    MOUNTAIN VIEW, Calif., April 23 /PRNewswire Interactive News Release/ --
 ACLARA BioSciences, Inc. (Nasdaq: ACLA) will conduct a public conference call
 at 10:00 a.m. EDT (7:00 a.m. PDT) on Thursday, April 26, 2001 to discuss
 first quarter 2001 financial results.
     A news release discussing ACLARA's first quarter 2001 financial results
 will be issued Thursday, April 26, 2001, at 9:00 a.m. EDT.
     Leading the conference call will be Joseph Limber, President and CEO of
 ACLARA BioSciences, Inc.
     A live webcast may be accessed by clicking on the following link several
 minutes before the event:
 
     http://www.vcall.com/NASApp/VCall/EventPage?ID=73563
 
     If you are unable to participate in the scheduled call, a replay will be
 made available at 800-642-1687 and accessed by the pass code:  793574.
     ACLARA BioSciences is a leading developer of microfluidic lab-on-a-chip
 technology, having access to the wide range of technology and intellectual
 property required to broadly address the genomics and pharmaceutical drug
 screening markets. The company is developing advanced tools for drug discovery
 and genomics using its proprietary microfluidics array technology and assay
 chemistries. By performing integrated sample processing and analysis on
 plastic microfluidic array LabCard(TM) chips, these tools enable the rapid,
 parallel processing of large numbers of samples while requiring only minute
 volumes of expensive or rare reagents.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X51752588
 
 SOURCE  ACLARA BioSciences, Inc.